Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Non Operating Investment Income (2024 - 2026)

Lantheus Holdings (LNTH) posted quarterly Non Operating Investment Income of $14.9 million for Q1 2026, up 200.29% year-over-year from $5.0 million in Q1 2025, and up 257.09% quarter-over-quarter from -$9.5 million in Q4 2025.

Lantheus Holdings (LNTH) Non Operating Investment Income (2024 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Non Operating Investment Income for 3 consecutive years, with $14.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non Operating Investment Income rose 200.29% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $21.2 million (up 117.75% YoY), while the FY2025 annual figure was -$8.6 million, up 80.22% from the prior year.
  • Non Operating Investment Income advanced to $14.9 million in Q1 2026 per LNTH's latest filing, from -$9.5 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $60.7 million in Q1 2024 and bottomed at -$119.1 million in Q4 2024.
  • Historically, Non Operating Investment Income has averaged -$4.1 million across 3 years, with a median of $1.2 million in 2025.
  • Annual changes were most pronounced in 2025 — Non Operating Investment Income tumbled 124.48% — and 2026, when it surged 200.29%.
  • Lantheus Holdings' Non Operating Investment Income stood at -$119.1 million in 2024, then soared by 92.03% to -$9.5 million in 2025, then jumped by 257.09% to $14.9 million in 2026.
  • Business Quant data shows LNTH's Non Operating Investment Income at $14.9 million in Q1 2026, -$9.5 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn -9.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.54 Mn
Jun 30, 2026 -9.54 Mn
Mar 31, 2026 14.91 Mn
Mar 31, 2026 14.91 Mn
Dec 31, 2025 -9.49 Mn
Dec 31, 2025 -9.49 Mn
Sep 30, 2025 1.16 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 14.57 Mn
Jun 30, 2025 14.57 Mn
Mar 31, 2025 -14.86 Mn
Mar 31, 2025 -14.86 Mn
Dec 31, 2024 -119.06 Mn
Dec 31, 2024 -119.06 Mn
Sep 30, 2024 37.33 Mn
Sep 30, 2024 37.33 Mn
Jun 30, 2024 -22.54 Mn
Jun 30, 2024 -22.54 Mn
Mar 31, 2024 60.70 Mn
Mar 31, 2024 60.70 Mn